High levels of serum soluble CD27 correlated with renal dysfunction

Clinical and Experimental Medicine

Volumn 2, Issue 4, 2003, Pages 192-196

  Nakatsuji, T ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD27 ligand; Lymphocyte malignancy; Renal tubule apoptosis; Soluble CD27

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIDIABETIC AGENT; ANTIGOUT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; CD27 ANTIGEN; CREATININE; DIURETIC AGENT; NITROGEN; UREA; VASODILATOR AGENT;

ACCURACY; ANEURYSM; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CORRELATION FUNCTION; CREATININE BLOOD LEVEL; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOLYSIS; HUMAN; KIDNEY DISEASE; KIDNEY TUBULE CELL; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ANEURYSM; ANTIGENS, CD27; APOPTOSIS; CREATININE; FEMALE; HEMOGLOBINS; HEMOLYSIS; HUMANS; KIDNEY DISEASES; KIDNEY NEOPLASMS; KIDNEY TUBULES; LYMPHOMA, B-CELL; MALE; MYELODYSPLASTIC SYNDROMES; PHARMACEUTICAL PREPARATIONS; PLATELET COUNT; STATISTICS;

EID: 0037293811     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s102380300006     Document Type: Article

References (13)

1. Hendriks J, Gravestein LA, Tesselaar K, Lier RAW van, Schumacher TNM, Borst J (2000) CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol 1:433-440
2. Moss ML, Jin S-LC, Milla ME et al (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385:733-736
3. Hintzen RQ, Jong R de, Hack CE et al (1991) A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex. J Immunol 147:29-35
4. Oers MHJ van, Pals ST, Evers LM et al (1993) Expression and release of CD27 in human B-cell malignancies. Blood 82:3430-3436
5. Padanilam BJ, Lewington AJP, Hammerman MR (1998) Expression of CD27 and ischemia/reperfusion-induced expression of its ligand Siva in rat kidneys. Kidney Int 54:1967-1975
6. Prasad KVS, Ao Z, Yoon Yet al (1997) CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc Natl Acad Sci U S A 94:6346-6351
7. Legallicier B, Trugnan G, Murphy G et al (2001) Expression of the type IV collagenase system during mouse kidney development and tubule segmentation. J Am Soc Nephrol 12:2358-2369
8. Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V (2002) Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 160:673-680
9. Carrell TWG, Burnand KG, Wells GMA, Clements JM, Smith A (2002) Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 105:477-482
10. Couser WG, Johnson RJ (1997) Postinfectious glomerulonephritis. In: Neilson EG, Couser WG (eds) Immunologic renal diseases. Lippincott-Raven, Philadelphia, pp 915-943
11. Wong VY, Keller PM, Nuttall ME et al (2001) Role of caspases in human renal proximal tubular epithelial cell apoptosis. Eur J Pharmacol 433:135-140
12. Cursio R, Mari B, Louis K et al (2002) Rat liver injury after normothermic ischemia is prevented by a phosphinic matrix metalloproteinase inhibitor. FASEB J 16:93-95
13. Lindsey ML, Gannon J, Aikawa M et al (2002) Selective matrix metalloproteinase inhibitor reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction. Circulation 105:753-758